SoniVie Clinical Practices Privacy Policy

SoniVie Ltd. and its affiliates (“SoniVie“, “we”, “us” or “our”) are focused on developing breakthrough technologies and devices to treat patient diseases, including renal artery denervation (RDN) and pulmonary arterial hypertension (PAH). This Privacy Policy (“Policy“) describes how we collect, store, use, and disclose the personal data (as defined in Section 1) of the following categories of data subjects, as a part of the clinical trials sponsored by SoniVie (“Trials”) and SoniVie’s patient recruitment practices for such Trials:

Study Participants: Individuals who have completed the evaluation process and have officially been enrolled in a Trial. These participants meet the specific eligibility criteria for the Trial and have provided informed and explicit consent via an Informed Consent Form (“ICF”) to take part in the Trial and for the processing of their personal data as a part of Trial (“Participants”);
Prospective Study Participants: Individuals who have shown interest in participating in our Trial but have not yet been fully enrolled. Prospective study participants may have completed an initial screening or questionnaire to assess their eligibility for the Trial. However, they are still in the process of being evaluated based on the Trial’s specific criteria. If they meet these criteria, they may move forward in the recruitment process. Until then, prospects remain as potential participants, and their information is securely handled throughout this process (“Prospects”);
Site Staff: Individuals who engage or communicate with SoniVie on behalf of study sites (“Sites”), such as the sites’ focal persons and points of contact with whom SoniVie communicates or engages, principal investigators, sub-investigators, or co-investigators, and other site staff whose personal data may be processed by SoniVie in the course of the Trials (collectively, “Site Members”);
Business Partners: Individuals who engage or communicate with SoniVie on behalf of our Service Providers and Research Partners (defined in Section 5), including their internal focal persons, points of contact, authorised signatories, billing contacts, etc.

Please read this Policy carefully and make sure that you fully understand it. If you have any questions, concerns or objections to SoniVie’s data processing practices described in this Policy, please reach out to us via [email protected].

If you are a Participant or Prospect, please note that your participation in a Trial (including its pre-screening process) is completely voluntarily. Prior to participating in a Trial, you must give explicit and informed consent in writing via an ICF (defined above) for your participation in the Trial and for the processing of your personal data as a part of it. If you are a Participant, please note that your ICF provides further information as to how your personal data will be processed for the purposes of the Trial. If you have any questions or concerns, please reach out to the doctor assigned to you who manages your participation in the Trial.

This Policy does not apply to the processing of personal data relating to visitors of our website at www.sonivie.com. If you are a website visitor, please refer to our website privacy policy.

Specifically, this Privacy Policy describes our practices regarding:

Data Collection & Processing
Data Uses
Data Location
Data Retention
Data Sharing
Cookies and Data Collection Technologies
Communications
Data Security
Data Subject Rights
Roles and Responsibilities
Opt-Out of Sale/Sharing
Additional Information and Contact Details

1. Collection and Processing of Personal Data

When we use the term “personal data” in this Policy, we mean information relating to an identified or identifiable individual. It does not include aggregated, de-identified or anonymized information that is maintained in a form that is not reasonably capable of identify an individual or being associated with or linked to an individual.

As a part of our Trials and recruitment campaigns for such Trials, SoniVie collects and processes the following types of personal data:

a. Personal Data of Prospects:

When you use our patient recruitment websites, landing pages, or ads (“Patient Recruitment Websites”), you will voluntarily provide personal data like your name, phone number, city, email address, and answers to a health questionnaire. If you are eligible to move forward in the recruitment process, we will assign you a unique serial number in our system (collectively, “Prospect Data”).

Prospect Data will be processed and stored by our designated and authorized Service Providers and Research Partners (defined below in Section 5), such as our data storage providers, client relationship management systems (CRM), our patient recruitment and campaign management providers and our authorized screeners who will manage your recruitment process.

Please note that SoniVie will not be able to identify any of the Prospects by name. Except for a unique serial number assigned to each of our Prospects, SoniVie will not have access to additional Prospect Data, nor to any personal data that directly identifies a Prospect (including any medical records or health data).

If you have any questions regarding the collection of your personal data, please reach out the screener assigned to you who manages your recruitment process.

b. Personal Data of Participants:

As a part of your participation in a Trial, SoniVie, its Service Providers and Research Partners (defined below in Section 5) and/or the Site will collect and process the following personal data about Participants:

Your demographic information including your name, initials, health insurance number, contact information, ethnicity, race, date of birth and sex (“Patient Information”);
Your medical records and health information collected as a part of the Trial, which include medical histories and questionnaires, as well as various test results (including genetic test results), lab results, scans, images, and bio samples, and location data (i.e., information indicating if an individual received treatment in a certain facility). (“Health Information”);
Study data relating to the manner in which SoniVie’s medical devices are performed and information regarding their effectiveness (to the extent they can be linked to or associated with a Participant), along with a unique patient ID assigned to each of the Participants by the Site conducting the Trial (i.e., a Patient ID) once the Participant signs the ICF (“Study Data”).

In accordance with applicable laws and to ensure data minimization and the confidentiality of our Participants, SoniVie will only have access to pseudonymized Study Data. This practice ensures that any identifying information and/or health data relating to Participants (i.e., their Patient and Health Information) will only be processed and by or disclosed to those persons and entities who need to use it for the purposes of the Trial (e.g., the relevant Site Members).

Personal data relating to Participants will only be processed in accordance with the applicable Study Protocol and ICF. For more information on how your personal data is processed as a part of the Trial, please refer to your ICF and/or reach out to the doctor assigned to you who manages your participation in the Trial.

Please note that SoniVie and the relevant Site may process Participants’ personal data as ‘Joint Controllers’ under the EU General Data Protection Regulation (“GDPR”) and Switzerland’s Federal Act on Data Protection (“FADP”). This means that SoniVie and the Site conducting your Trial jointly determine the purposes and means of the processing of your personal data. As required under the GDPR or FADP, SoniVie and the Site has entered into a written contract governing their joint processing of your personal data and respective obligations and responsibilities, requiring each of the parties to process personal data in accordance with applicable laws. Each of the parties will process your personal data in accordance with its privacy policy and the applicable Study Protocol and ICF. For more information on how your personal data is processed, please refer to your ICF or reach out to your assigned doctor, who’s contact details can be found in your ICF.

c. Personal Data of Site Members and Business Partners:

We process the following types of personal data about Site Members: contact details, such as name, and address, position, identification number, personal data included in contracts we and our Sites have in place, qualifications, publications and information contained in the CV you provide to us where necessary, previous experience and other information regarding your participation in clinical trials and the training you have received, and technical and usage data about your use of SoniVie’s systems.

For the purposes of the California Consumer Privacy Act (“CCPA”), in the last 12 months, we (or our Service Providers) may have collected the following categories of Personal Information, as defined in the CCPA: identifiers; customer record information; internet or other electronic network activity information; professional or employment-related information; geolocation data; sensitive personal information; and commercial information.

2. Data Uses and Purposes of Processing

SoniVie process personal data for the following business and commercial purposes, and in reliance on the lawful bases for processing noted next to them, as appropriate.

Personal Data of Prospects
To facilitate, operate and manage the recruitment process for our Trials;	Legitimate Interest. As a part of the recruitment process, we will use authorized Service Providers to store and manage your personal data. SoniVie will not be exposed to such personal data managed on SoniVie’s behalf.
To assess whether a Prospect is eligible to participate in a Trial, i.e., to filter out Prospects who are not suitable for our Trial, ensuring that only those who are likely to meet the criteria proceed to the next stage of the recruitment process;	Consent. Your health personal data that is included in your Prospect Data provided as a part of the recruitment process will be processed by SoniVie and its Service Providers in reliance on your consent (which will be obtained upon the collection of your Prospect Data). You can withdraw your consent at any time. If you do so, you will not be able to take part in the recruitment for the trial, and your Prospect Data will be deleted within 48 hours.
To contact Prospects in order to provide information as to their recruitment process;	Legitimate Interest. If our patient recruitment screeners will determine that you meet the basic eligibility criteria for participation in the Trial, they will use your contact details to reach out to you and inform you of the next steps.
To improve our recruitment process, including by generating analytics on how our patient-recruitment websites, landing pages and ads perform, and use such analytics to improve them.	Legitimate interest. We use analytics tools that monitor the use of our patient-recruitment websites, landing pages and ads. We use such analytics to assess and understand how our recruitment pages work and what can be done to improve them.
To comply with applicable requirements, such as good clinical practices (“GCPs”) and regulatory requirements to which SoniVie is subject.	Compliance with legal obligations.
Personal data of Participants
Study Data
To facilitate, operate, and manage our Trial and medical devices;	Legitimate Interest.
To test the functionality of our medical device, monitor its effectiveness and improve its performance, and to further develop our medical devices;	Legitimate Interest. We process pseudonymized Study Data in reliance on our legitimate interest to improve our services and capabilities in order to be able to conduct effective Trial and derive high-quality results and data from our Trials
To perform audits, research, measurements and analyses in an effort to maintain, administer, support, analyze, enhance, and ensure the safety of the Trial and our medical devices;	Legitimate Interest.
To comply with applicable requirements, such as good clinical practices (“GCPs”) and regulatory requirements to which SoniVie is subject.	Compliance with legal obligations.
Patient Information
To facilitate, operate, and manage our Trial and medical devices;	Legitimate Interest.
To perform audits, research, measurements and analyses in an effort to maintain, administer, support, analyze, enhance, and ensure the safety of the Trial and our medical devices;	Legitimate Interest.
To answer the research questions of the Trial and to aggregate data in order to generate statistics (i.e., Study Data) relating to the Trial and/or health treatment;	Legitimate Interest.
To process reimbursement payments for your time and travel related to study participation;	Legitimate Interest.
To communicate with you on the status of the Trial, to send you reminders on appointments at the Site, to respond to your inquiries or questions, or any other communication that is necessary as a part of the Trial and your participation;	Legitimate Interest.
Personal data of Site Members and Business Partners
To facilitate, operate, and manage our Trial;	Legitimate Interest.
To perform audits and monitor the Trial and to perform additional administration tasks and support in order to ensure effective, compliant and safe practices;	Legitimate Interest; Compliance with Legal Obligations.
To contact Site Members with general or personalized Trial and/or related messages;	Legitimate Interest.
To support and enhance our data security measures, including for the purposes of preventing and mitigating the risks of fraud, error or any illegal or prohibited activity;	Legitimate Interest; Compliance with Legal Obligations.
To enforce our agreements, to resolve disputes, to carry out our obligations and enforce our rights, and to protect our business interests and the interests and rights of third parties;	Legitimate Interest.

3. Data Location

We and our authorized Service Providers, Research Partners and Sites (as detailed in Section 5 below) maintain, store and process personal data in Europe, Israel and the United States of America, and other locations as reasonably necessary for the proper performance of our Trial and patient recruitment process, or as may be required by law.

SoniVie is headquartered in Israel, a jurisdiction which is considered by the European Commission and the Swiss Federal Data Protection and Information Commissioner (FDPIC) to be offering an adequate level of protection to personal data of residents of the European Economic Area (“EEA”) and Switzerland, respectively. We transfer personal data to Israel on this basis. For data transfers from the EEA or Switzerland to countries which are not considered to be offering an adequate level of data protection (including to SoniVie Inc., our US affiliate company), we ensure to enter into Standard Contractual Clauses with the relevant data exporters and importers, as approved by the European Commission and FDPIC. You can obtain a copy of these clauses by contacting us as indicated in Section 11 below.

While privacy laws may vary between jurisdictions, SoniVie is committed to protect personal data in accordance with this Privacy Policy, and such appropriate lawful mechanisms and contractual terms requiring adequate data protection, regardless of any lesser legal requirements that may apply in the jurisdiction to which such data is transferred.

4. Data Retention

We retain personal data for the purposes outlined in this Policy; for as long as it reasonably necessary for our legitimate business purposes and for the performance of our Trials; in order to comply with our legal and contractual obligations, for archiving purposes in the public interest and/or for scientific research purposes as part of the Trial, or to protect ourselves from any potential disputes (i.e. as required by laws applicable to log-keeping, records and bookkeeping, and in order to have proof and evidence concerning our relationship, should any legal issues arise following your discontinuance of use), all in accordance with applicable laws and regulations, and as further stipulated in the data processing agreements and other contracts we have with Sites, Service Providers and Research Partners. Please also note that we may also retain personal data due to the laws and regulations relating to clinical trials, depending on the jurisdiction in which the Trial is conducted.

Please note that except as required by applicable law or regulations or our specific agreements with you, we will not be obligated to retain your personal data for any particular period, and we are free to securely delete it or restrict access to it for any reason and at any time, with or without notice to you.

5. Data Disclosures

Legal Compliance: we may disclose or allow government and law enforcement officials access to your personal data, in response to a subpoena, search warrant or court order (or similar requirement), or in compliance with applicable laws and regulations with or without notice to you. Such disclosure or access may occur if we believe in good faith that: (a) we are legally compelled to do so and solely to the extent that we believe is strictly necessary to comply, (b) disclosure is appropriate in connection with efforts to investigate, prevent, or take action regarding actual or suspected illegal activity, fraud, or other wrongdoing; or (c) such disclosure is required to protect our legitimate business interests. Please also note that we may also disclose personal data to the regulatory bodies to which we are subject in relation to the conducting of Trials such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA).

Service Providers and Research Partners: we may engage selected third-party companies and individuals to perform services complementary to our own, such as hosting and server co-location services, communications and content delivery networks (CDNs), data analytics services, marketing and advertising services, data and cyber security services, billing and payment processing services, e-mail and SMS distribution and monitoring services, procedure or activity recording services, performance measurement, data optimization services, social and advertising networks, content providers, support and customer relation management systems, and our business, legal, financial and compliance advisors (collectively, “Service Providers“); and, solely for the purposes of conducting the Trial (including for the patient recruitment process), core laboratories, clinical research organizations (CROs), clinical research associates and assistants (CRAs), patient recruitment screeners, patient recruitment services, customer relation management tools, Trial campaign providers, proctors, and electronic data capture systems (EDC) (collectively, “Research Partners”). These Service Providers and Research Partners may have access to your personal data, depending on each of their specific roles and purposes in facilitating and supporting the Trial, and may only use it for such purposes.

Trial Sites: Personal data of Participants is typically shared and is available between SoniVie and the respective Site where the Trial takes place. In such cases, sharing such data means that relevant Site Members may access it on behalf of the Site, and will be able to monitor, process and analyze the personal data of Participants. This includes instances where the Site will notify your care provider of your potential health problem in real-time.

Please note that SoniVie is not responsible for and does not control any further processing of personal data (including any disclosure, use, or monitoring) by, or on behalf of, the Site of which you are a data subject (as an employee or patient for example), in instances where the Site acts as an independent and separate Data Controller of your personal data (as further described in Section 10 below).

Protecting Rights and Safety: we may share personal data with others if we believe in good faith that this will help protect the rights, property or personal safety of SoniVie, Prospects, Participants, Site Members, Service Providers, Research Partners or any members of the general public.

SoniVie Subsidiaries and Affiliated Companies; Change of Control: we may share personal data internally within our group, for the purposes described in this Privacy Policy. In addition, should SoniVie or any of its subsidiaries or affiliates undergo any change in control or ownership, including by means of merger, acquisition or purchase of substantially all or part of its assets, or will be considered or found eligible for a governmental grant, personal data may be shared with the parties involved in such an event. If we believe that such an event might materially affect your personal data, we will notify you of this event and the choices you may have via the means available to us (depending on the type of data subject involved).

For the avoidance of doubt, SoniVie may disclose your personal data in additional manners, pursuant to your explicit approval, or if we are legally obligated to do so, or if we have successfully rendered such data non-personal, non-identifiable and anonymous. We may transfer, share or otherwise use non-personal and non-identifiable data at our sole discretion and without the need for further approval.

For the purposes of the CCPA, in the past 12 months we may have disclosed the following categories of Personal Information, as defined in the CCPA: identifiers; customer record information; internet or other electronic network activity information; professional or employment-related information; geolocation data; sensitive personal information; and commercial information. We do so in pursuit of the business and commercial purposes described in Section 2 above.

6. Cookies and Data Collection Technologies

We and our Service Providers use cookies, pixels and other data collection technologies for performance, tracking, analytics and personalization purposes and in order to provide our Prospects with a better experience on our Patient Recruitment Websites. We may share non-identifiable/aggregated extracts of such information with some of our Service Providers for the purposes described above in Section 2.

Cookies are packets of information sent to your web browser and then sent back by the browser each time it accesses the server that sent the cookie. Some cookies are removed when you close your browser session. These are the “Session Cookies”. Some last for longer periods and are called “Persistent Cookies”. We use both types.

Some cookies are necessary for the Patient Recruitment Websites to function properly, and cannot be declined or disabled unless you delete and block them through your web browser settings. Other cookies, which are used for functional, performance, analytics and marketing purposes, are optional. These include Google Analytics cookies and Facebook pixels.

Google Analytics is a tool provided by Google LLC. that helps us understand users’ behavior on our Patient Recruitment Websites, including by tracking page content, and click/touch, movements, scrolls and keystroke activities. We use such data to understand how Prospects engage with our Patient Recruitment Websites, and how we can improve those websites and the Prospects’ user experience. Further information about the privacy practices of Google Analytics is available at: www.google.com/policies/privacy/partners/. Further information about your option to opt-out of Google Analytics is available at: https://tools.google.com/dlpage/gaoptout.
Facebook Pixel is a tool provided by Meta (formerly Facebook) that helps us track user interactions with our advertisements. When you click on one of our clinical trial ads on Facebook, the Pixel is triggered, and we collect information such as your device type, operating system, browser type, and the specific pages you visit on our Patient Recruitment Websites, including the fact that you arrived from a Facebook ad. The Pixel also tracks actions like filling out forms on our landing page to help us understand the effectiveness of our recruitment efforts. This data may also be used by Facebook to improve the targeting of ads that you see. For more information on how Facebook collects and processes your data, please refer to Meta’s Data Policy. You can manage the information Meta collects about you and exercise your privacy rights in relation to such information by clicking on the following link: https://www.facebook.com/privacy/guide/collection.

You may opt-in or opt-out to the use of such optional cookies by pressing the floating cookie widget available on our Patient Recruitment Website’s footer at https://sonivie-research.com/. If you choose to opt-out of certain cookies, this will typically generate a new cookie which will preserve your choice, and indicate it to our Patient Recruitment Websites in your next visits so that the cookies you opted-out of will not be utilized. You can also manage your cookies preferences, and accept, remove or entirely block cookies, through your browser settings. Certain web browsers may transmit “Do Not Track” signals to websites with which the browser communicates. However, due to differences in how web browsers interpret this feature and send those signals, and lack of standardization, we currently do not respond to such “Do Not Track” signals.

Please note that if you get a new device, install a new browser, erase or otherwise alter your browser’s cookie file (including upgrading certain browsers), you may also clear the opt-out cookies installed once you opt-out, so an additional opt-out will be necessary to prevent additional tracking.

For more information on the cookies we use, please visit the cookie banner on our Patient Recruitment Website at https://sonivie-research.com/.

7. Communications

Service Communications: we may contact you with important information regarding our Trial or related services. For example, we may send you notifications (through any of the means available to us) of changes or updates to our Privacy Policy, billing issues, service changes etc. Our Sites and Site Members may also send notifications, messages and other updates regarding the Trial to Participants. Other Service Providers and Research Partners (e.g., our patient recruitment screeners) may contact our Prospects with important information regarding their recruitment process. Please note that you will not be able to opt-out of receiving certain Trial or patient recruitment related communications which are integral to our business engagement or your participation in the Trial and/or the pre-screening and recruitment process.

8. Data Security

We implement systems, applications and procedures to secure personal data, to minimize the risks of theft, damage, loss of information, or unauthorized access or use of information. These measures provide sound industry-standard security, taking the GDPR into consideration. In addition, whenever we disclose personal data to another party (such as a Service Provider, Research Partner or Site) we make sure to require them to protect and safeguard personal data in accordance with applicable laws. However, although we make efforts to protect your privacy and data, we cannot and do not guarantee the absolute protection and security of any personal data stored with us or with any third-parties.

9. Data Subject Rights

Under the GDPR,FADP, CCPA and similar US-state privacy laws, individuals have the following rights with respect to their personal data (to the extent applicable): the right to know/request access to (specific pieces of personal data collected; categories of personal data collected; categories of sources from whom the personal data was collected; purpose of collecting personal data; categories of third parties with whom we have shared personal data), to request rectification or erasure of your personal data held with SoniVie, or to restrict or object to the processing of such personal data (including the right to direct us not to sell or share your personal data to third parties now or in the future, as described below), to port such personal data, the right to equal services and prices, or the right not to be subject to a automated decision making (please note that SoniVie do not carry out automated decision making with respect to personal data). GDPR or FADP-protected individuals, also have the right to lodge a complaint with the relevant supervisory authority in the EU or Switzerland, as appropriate.

To the extent applicable to you, you may also designate an authorized agent, in writing or through a power of attorney, to request to exercise your privacy rights on your behalf. The authorized agent may submit a request to exercise these rights by emailing us.

If you are a Site Member, please reach out to your trial administrator or contact us by email at [email protected] if you wish to exercise your privacy rights available to you under the GDPR or FADP.
If you are a Prospect, please reach out to the screener managing your recruitment process, if you wish to exercise your rights available to you under the GDPR or FADP.
If you are a Trial Participant, please reach out to the doctor managing your participation in the Trial, whose contact details can be found in your ICF, if you wish to exercise your rights available to you under the GDPR or FADP.

Please note that when we are requested to exercise privacy rights under this Policy, the GDPR, FADP, CCPA or any other privacy law that applies to you, we may need to ask you (or your authorized agent, where applicable) to provide us certain credentials or details to make sure that you are who you claim you are, to avoid disclosure to you of personal data related to others and to ask you to provide further information to better understand the nature and scope of data that you request to access. Such additional data will be then retained by us for legal purposes (e.g. as proof of the identity of the person submitting the request), in accordance with Section 4 above. We may redact from the data which we will make available to you any personal data related to others.

10. Roles and Responsibilities

The GDPR, FADP, California Consumer Privacy Act (CCPA) and other similar US states privacy laws, typically distinguish between two main roles for parties processing personal data: the “Controller” (or under the CCPA, ”Business”), who determines the purposes and means of processing; and the “Processor” (or under the CCPA, “Service Provider”), who processes the personal data on behalf of the Controller. Below we explain how these roles apply to our processing of personal data, to the extent that such laws and regulations apply.

SoniVie is the Controller of personal data relating to Prospects, Site Members, Service Providers and Research Partners. In such instances, SoniVie’s Service Providers (as detailed in Section 5) processing such data on our behalf assume the role of Processors. Our Processors may only process personal data on SoniVie’s documented instructions and the Data Processing Agreements (“DPA”) we have with them, and may not use the personal data for purposes that are not defined in the DPA.

With respect to personal data of Trial Participants, SoniVie and the respective Site typically process personal data as “Joint Controllers”. As required under the GDPR and FADP, SoniVie ensures to have in place a DPA with each Site that allocates the parties’ respective responsibilities with respect to the processing of Participants’ personal data. SoniVie and the respective Site may only process Participants’ personal data in accordance with the DPA, the GDPR or FADP (as applicable) and other applicable regulatory requirements, the applicable ICF and Study Protocol. The Service Providers and Research Partners that process Participants’ personal data, will assume the role of a Processor. However, there might be cases where Sites will process personal data as SoniVie’s processors. In such a case, we will have a DPA with the Site ensuring that they can only process data in accordance with SoniVie’s instructions. In any case, SoniVie will always be the data controller of personal data relating to Trial Participants.

The Health Insurance Portability and Accountability Act (HIPAA) also distinguish between two main parties who process Protected Health Information (PHI) of individuals in the USA. These are “Covered Entities” – who are directly subject to HIPAA, such as healthcare providers that process PHI, and “Business Associates”, i.e., their service providers who process PHI on the Covered Entities’ behalf.

Please note that under HIPAA, the Covered Entity of PHI processed as a part of the Trial is the respective Site conducting the Trial in which you participate. If you are a Participant in any of our USA-based Trials, please refer to the Site’s privacy policies to find more information about how your PHI is being processed.

11. Opt-Out of Sale/Sharing

Under some US data protection laws, like the CCPA, our disclosure of certain internet activity and device information with third parties through cookies on our Patient Recruitment Websites may be considered a “sale” or “sharing” of personal information. We do so in pursuit of the business and commercial purposes described in Section 2 above.

For the purposes of the CCPA, in the last 12 months we may have “sold” or “shared” Internet or other electronic network activity information, Geolocation data, Commercial information, and Inferences with our analytics and advertising Service Providers. SoniVie has not knowingly sold or shared the personal information of individuals under the age of 16.

You may opt out of all cookies that may result in a “sale” and/or “sharing” of your personal information in the following ways:

Click the “Consent Preferences” button (available in our Patient Recruitment Website’s footer at https://sonivie-research.com/), move the toggle switch next to “Share or Sale of Personal Information” to grey (disabled), then click the “Save my Preferences” button.

Please note: If you visit us from a different device or browser, or clear cookies, then you need to return to this screen to re-select your preferences.

Set the Global Privacy Control (GPC) for each participating browser system that you use to opt out of the use of third-party Advertising or other cookies (instructions on how to download and use GPC are available

12. Additional Information and Contact Details

Updates and amendments: We may update and amend this Policy from time to time. The amended version will be effective as of the date it is published. We will provide prior notice if we believe any substantial changes are involved via any of the communication means available to us. After such notice period, all amendments shall be deemed accepted by you. If you are a Trial Participant, please note that we will not make any update to your ICF without obtaining your prior consent.

Data Protection Officer: SoniVie has appointed PrivacyTeam Ltd. as its Data Protection Officer (DPO), for monitoring and advising on SoniVie’s ongoing privacy compliance and serving as a point of contact on privacy matters for data subjects and supervisory authorities. If you have any comments or questions regarding our Privacy Policy, if you have any concerns regarding your privacy, or if you wish to make a complaint about how your personal data is being processed by SoniVie, you can contact [email protected].

EU & Switzerland Representative

Questions, concerns or complaints: if you have any comments or questions regarding our Privacy Policy, or if you have any concerns regarding your personal data, please contact us at [email protected].

Last Updated: September 2024.